Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-01-17 Sale | 2024-01-19 5:19 pm | PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer | 9,781 | $17.23 | $168,527 | 194,605 (Direct) | View |
2024-01-17 Sale | 2024-01-19 5:19 pm | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 9,786 | $17.23 | $168,613 | 216,860 (Indirect Direct) | View |
2024-01-17 Sale | 2024-01-19 5:19 pm | PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO | 25,721 | $17.23 | $443,173 | 725,699 (Indirect Direct) | View |
2024-01-17 Sale | 2024-01-19 5:18 pm | PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer | 10,295 | $17.23 | $177,383 | 156,920 (Direct) | View |
2024-01-17 Sale | 2024-01-19 5:11 pm | PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y | 5,197 | $17.23 | $89,544 | 55,246 (Direct) | View |
2023-08-03 Sale | 2023-08-07 8:50 pm | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 34,919 | $20.01 | $698,581 | 298,171 (Indirect Direct) | View |
2023-07-20 Sale | 2023-07-21 4:40 pm | PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y | 4,755 | $17.55 | $83,450 | 60,443 (Direct) | View |
2023-07-17 Sale | 2023-07-19 8:31 pm | PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y | 12,778 | $18.01 | $230,120 | 65,198 (Direct) | View |
2023-07-17 Sale | 2023-07-19 8:29 pm | PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer | 22,321 | $18.01 | $401,981 | 167,215 (Direct) | View |
2023-07-17 Sale | 2023-07-19 8:26 pm | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 17,937 | $18.01 | $323,029 | 250,974 (Indirect Direct) | View |
2023-07-17 Sale | 2023-07-19 8:23 pm | PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer | 19,771 | $18.01 | $356,058 | 203,999 (Direct) | View |
2023-07-17 Sale | 2023-07-19 8:20 pm | PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO | 70,150 | $18.01 | $1,263,338 | 751,420 (Indirect Direct) | View |
2023-03-30 Sale | 2023-04-03 7:07 pm | PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y | 7,751 | $26.62 | $206,329 | 50,789 (Direct) | View |
2023-03-30 Sale | 2023-04-03 7:01 pm | PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer | 11,245 | $26.52 | $298,228 | 145,786 (Direct) | View |
2023-03-30 Sale | 2023-04-03 6:51 pm | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 9,036 | $26.52 | $239,643 | 233,755 (Indirect Direct) | View |
2023-03-30 Sale | 2023-04-03 6:48 pm | PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer | 9,960 | $26.52 | $264,148 | 148,470 (Direct) | View |
2023-03-30 Sale | 2023-04-03 6:46 pm | PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO | 35,339 | $26.52 | $937,222 | 684,070 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-01-23 Option Award | 2024-01-24 4:58 pm | N/A 2034-01-23 | PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer | 128,700 | $0 | 285,620 (Direct) | View |
2024-01-23 Option Award | 2024-01-24 4:57 pm | N/A 2034-01-23 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 94,500 | $0 | 311,360 (Direct) | View |
2024-01-23 Option Award | 2024-01-24 4:57 pm | N/A 2034-01-23 | PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y | 94,500 | $0 | 149,746 (Direct) | View |
2024-01-23 Option Award | 2024-01-24 4:57 pm | N/A 2034-01-23 | PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer | 165,750 | $0 | 360,355 (Direct) | View |
2024-01-23 Option Award | 2024-01-24 4:57 pm | N/A 2034-01-23 | PLIANT THERAPEUTICS INC. | PLRX | Cheung Lily Chief Human Resource Officer | 78,000 | $0 | 78,795 (Direct) | View |
2024-01-23 Option Award | 2024-01-24 4:56 pm | N/A 2034-01-23 | PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO | 384,450 | $0 | 1,110,149 (Direct) | View |
2023-08-03 Exercise | 2023-08-07 8:50 pm | N/A 2028-03-31 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 10,591 | $0 | 298,171 (Direct) | View |
2023-08-03 Exercise | 2023-08-07 8:50 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 10,591 | $2.08 | 298,171 (Direct) | View |
2023-07-14 Option Award | 2023-07-18 7:26 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y | 27,187 | $0 | 77,976 (Direct) | View |
2023-07-14 Option Award | 2023-07-18 7:22 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer | 43,750 | $0 | 189,536 (Direct) | View |
2023-07-14 Option Award | 2023-07-18 7:19 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 35,156 | $0 | 268,911 (Direct) | View |
2023-07-14 Option Award | 2023-07-18 7:17 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer | 38,750 | $0 | 223,770 (Direct) | View |
2023-07-14 Option Award | 2023-07-18 7:14 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO | 137,500 | $0 | 821,570 (Direct) | View |
2023-06-13 Exercise | 2023-06-14 6:14 pm | N/A 2029-01-24 | PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer | 30,750 | $0 | 282,067 (Direct) | View |
2023-06-13 Exercise | 2023-06-14 6:14 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer | 30,750 | $2.08 | 282,067 (Direct) | View |
2023-06-09 Exercise | 2023-06-12 6:19 pm | N/A 2029-01-24 | PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer | 5,800 | $0 | 282,067 (Direct) | View |
2023-06-09 Exercise | 2023-06-12 6:19 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer | 5,800 | $2.08 | 282,067 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:26 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | Shah Smital Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:24 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | PYOTT DAVID E I Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:22 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | MCCOURT Thomas A Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:19 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | Knobil Katharine Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:16 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | Huh Hoyoung Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:14 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | Curnutte John T Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:11 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | CROWELL GAYLE A Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:09 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | Cline Darren S Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:06 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | Bruhn Suzanne Louise Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-03-29 Option Award | 2023-03-31 6:05 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y | 13,593 | $0 | 58,540 (Direct) | View |